E-mail Updates- Home
- Tools and Resources
- CME/CE Activities
CME/CE Activities
The CME/CE activities listed below are offered by different credit providers, each having unique requirements for earning a credit certificate or a certificate of participation. Please review their requirements carefully.
If you are engaged in educating clinicians, researchers, and other health professionals, please see the EHC Program Slide Library for presentation resources.
CME/CE activities are available for the following health conditions and methods areas:
- Breathing Conditions
- Cancer
- Developmental Delays, ADHD, Autism
- Diabetes
- Digestive System Conditions
- Genitourinary Conditions
- Gynecology
- Heart and Blood Vessel Conditions
- Infectious Diseases and HIV/AIDs
- Mental Health
- Muscle, Bone, and Joint Conditions
- Renal Disease
- AHRQ Training Modules for the Systematic Reviews Methods Guide
- Other Topics
Breathing Conditions
Guidance for Informed and Shared Decision Making about Diagnostic Tools and Treatments for Obstructive Sleep Apnea
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: October 31, 2011 – October 31, 2013.
Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea
- Physician
Sponsor: Baylor College of Medicine. Term of approval: August 2011 – August 2014.
Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis
- Physician
Sponsor: Baylor College of Medicine. Term of approval: March 2011 – March 2014.
Cancer
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Weighing the
Options
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: August 31, 2011 – August 30, 2013.
Comparative Effectiveness of Therapies for Reducing the Risk of Primary Breast Cancer: Guidance for Shared Decision Making
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: July 29, 2011 – July 28, 2013.
Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
- Physician
Sponsor: Baylor College of Medicine. Term of approval: November 2010 – November 2013.
Developmental Delays, ADHD, Autism
Comparing Pharmacologic, Behavioral, and Psychosocial Interventions for Attention Deficit Hyperactivity Disorder in Children
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: January 31, 2012 – January 30, 2014.
Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June 2014.
Diabetes
Practical Application of Shared and Informed Treatment Decisions Based on Comparative Effectiveness Research: Addressing the Needs of Underserved Patients with Type 2 Diabetes Mellitus New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.
AHRQ's Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings
- Physician
- Pharmacist
- Nurse
- Medical Assistant
- Case Manager
Sponsor: PRIME®. Term of approval: January 31, 2012 – September 30, 2013.
Comparing the Benefits and Risks of Oral Medications for Type 2 Diabetes: An Interactive, Case-Based Approach
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
- Dietician
Sponsor: PRIME®. Term of approval: January 31, 2012 – January 30, 2014.
Management of an Adult With Type 2 Diabetes With Antidiabetic Medications: A Case Scenario
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June, 2014.
Comparing Medicines for Type 2 Diabetes
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June, 2014.
Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults with Type 2 Diabetes
- Physician
- Pharmacist
- Nurse
- Case Manager
Sponsor: PRIME®. Term of approval: March 31, 2011 – March 30, 2013.
Comparative Effectiveness Research on Premixed Insulin Analogues for Type 2 Diabetes: Discussing Applications to Clinical Practice
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: March 31, 2011 – March 30, 2013.
Digestive System Conditions
Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update New!
- Physician
Sponsor: Baylor College of Medicine;. Term of approval: May 2012 – May 2015.
Updates on the Comparative Effectiveness of Management Strategies for Adults with Gastroesophageal Reflux Disease
- Physician
- Pharmacist
- Nurse
- Medical Assistant
- Case Manager
Sponsor: PRIME®. Term of approval: October 31, 2011 – October 31, 2013.
Genitourinary Conditions
Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness New!
- Physician
Sponsor: Baylor College of Medicine. Term of approval: May 2012 – May 2015.
Nonsurgical Treatments for Urinary Incontinence in Adult Women: Improving Informed Decision-Making through Patient Education New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: April 30, 2012 – April 29, 2014.
Gynecology
Noncyclic Chronic Pelvic Pain Therapies for Women New!
- Physician
Sponsor: Baylor College of Medicine. Term of approval: April 2012 – April 2015.
Clinical Applications of Comparative Effectiveness of Noncyclic Chronic Pelvic Pain Therapies for Women New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.
Heart and Blood Vessel Conditions
Self-Measured Blood Pressure Monitoring
- Physician
Sponsor: Baylor College of Medicine. Term of approval: February 2012 – February 2015.
ACEIs, ARBs, or DRI for Adults With Hypertension
- Physician
Sponsor: Baylor College of Medicine. Term of approval: October 2011 – October 2014.
Updates on the Treatment of Essential Hypertension: A Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Case Manager
Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.
Updates on the Comparative Effectiveness of Renin-Angiotensin-Aldosterone System Therapies for Essential Hypertension: A Feedback-Based Learning Activity
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.
AHRQ's Comparative Effectiveness Research on Angiotensin-Directed Therapies for Stable Ischemic Heart Disease: Applying the Results in Practice
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: June 30, 2011 – June 29, 2013.
Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
- Physician
- Pharmacist
- Nurse
- Case Manager
Sponsor: PRIME®. Term of approval: May 31, 2011 – May 31, 2013.
AHRQ’s Comparative Effectiveness Research on Lipid-Modifying Therapies
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
Sponsor: PRIME®. Term of approval: March 31, 2011 – March 30, 2013.
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
- Physician
Sponsor: Baylor College of Medicine. Term of approval: July 2010 – July 2013.
Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
- Physician
Sponsor: Baylor College of Medicine. Term of approval: July 2010 – July 2013.
Comparative Effectiveness of In-Hospital Off-Label Use of Recombinant Factor VIIa vs. Usual Care
- Physician
Sponsor: Baylor College of Medicine. Term of approval: October 2010 – October 2013.
Infectious Diseases and HIV/AIDs
Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
- Physician
Sponsor: Baylor College of Medicine. Term of approval: December 2011 – December 2014.
Mental Health
Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults New!
- Physician
Sponsor: Baylor College of Medicine;. Term of approval: March 2012 – March 2015.
Applying AHRQ's Comparative Effectiveness Research in Nonpharmacological Treatment of Depression and Discussion in Military Settings
- Physician
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: November 30, 2011 – November 30, 2013.
Traumatic Brain Injury and Depression
- Physician
Sponsor: Baylor College of Medicine. Term of approval: April 2011 – April 2014.
Muscle, Bone, and Joint Conditions
Preventing Fractures in Patients with Osteoporosis or Low Bone Density: A Review of the Evidence New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: April 30, 2012 – April 29, 2014.
Comparative Effectiveness and Safety of Analgesics for Osteoarthritis: A Panel Discussion With Applications to Practice New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.
Analgesics for Osteoarthritis–An Update
- Physician
Sponsor: Baylor College of Medicine. Term of approval: February 2012 – February 2015.
Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis. New!
- Physician
- Pharmacist
- Nurse
- Medical Assistant
- Case Manager
Sponsor: PRIME®. Term of approval: March 1, 2012 – September 30, 2013.
Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis
- Physician
- Pharmacist
- Nurse
- Medical Assistant
Sponsor: PRIME®. Term of approval: December 31, 2011 – December 31, 2013.
Comparative Effectiveness of Pain Management Interventions for Hip Fractures: A Feedback-Based Learning Activity
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.
Pain Management Interventions for Hip Fracture
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June 2014.
Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears
- Physician
Sponsor: Baylor College of Medicine. Term of approval: October 2010 – October 2013.
Renal Disease
Comparative Effectiveness Research: Screening, Monitoring, and Treatment in Early Chronic Kidney Disease New!
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME®. Term of approval: March 1, 2012 through February 28, 2014.
AHRQ Training Modules for the Systematic Reviews Methods Guide
Topic Refinement
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Analytic Frameworks
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Study Eligibility Criteria
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Searching for Relevant Studies
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
When To Select Observational Studies as Evidence
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Data Extraction
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Assessing the Quality of Individual Studies
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Assessing Applicability
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Presentation of Findings
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Quantitative Synthesis I
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Quantitative Synthesis II
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Grading Strength of Evidence
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Reporting the Review
- Physician
Sponsor: Baylor College of Medicine. Term of approval: June 2010 through June 2013.
Other Topics
Understanding Comparative Effectiveness Research and Applicability to Practice
- Physician
- Pharmacist
- Nurse
- Nurse Practitioner
- Medical Assistant
- Case Manager
- Health Education Specialist
Sponsor: PRIME® Term of approval: April 30, 2012 – April 29, 2014.
Evidence-Based Medicine for Pharmacists in the Patient-Centered Medical Home (PCMH)
- Pharmacist
Sponsor: American Pharmacists Association. Initial Release Date: December 13, 2010.
